Join the Paxlovid group to help and get support from people like you.
Paxlovid News
Paxlovid May Offer Little Benefit for Vaccinated Older Adults
THURSDAY, March 6, 2025 -- The antiviral drug Paxlovid may not offer much protection against COVID-related hospitalizations or deaths for vaccinated older adults after all. Research published ...
Extended Nirmatrelvir/Ritonavir Beneficial for Some With Long COVID
WEDNESDAY, Jan. 8, 2025 – Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist, according to a case series...
Despite Previous Data, Paxlovid May Be Useful for Long Covid After All
WEDNESDAY, Jan. 8, 2024 – The antiviral pill Paxlovid might help some patients who are suffering from long COVID. A five-day course of Paxlovid is known to help limit symptoms and shorten illness in...
FDA Approves Paxlovid (nirmatrelvir tablets and ritonavir tablets) for Adult Patients at High Risk of Progression to Severe COVID-19
NEW YORK--(BUSINESS WIRE) May 25, 2023 – Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) approved Paxlovid™ (nirmatrelvir tablets and ritonavir tablets) for t...